EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case T-1122/23: Action brought on 28 November 2023 — Nouryon Functional Chemicals and Others v ECHA

ECLI:EU:UNKNOWN:62023TN1122

62023TN1122

November 28, 2023
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

Official Journal of the European Union

EN

Series C

C/2024/770

(Case T-1122/23)

(C/2024/770)

Language of the case: English

Parties

Applicants: Nouryon Functional Chemicals BV (Amsterdam, Netherlands), Arkema GmbH (Düsseldorf, Germany), Pergan Hilfsstoffe für industrielle Prozesse GmbH (Bocholt, Germany), United Initiators GmbH (Pullach im Isartal, Germany) (represented by: R. Cana and Z. Romata, lawyers)

Defendant: European Chemicals Agency

Form of order sought

The applicants claim that the Court should:

declare the application admissible and well-founded;

annul the Decision of 19 September 2023 of the European Chemicals Agency, issued by the Agency’s Board of Appeal in Case A-009-2022 insofar as it requires the applicants to submit information on an extended one generation reproductive toxicity study under column 1 of Section 8.7.3 of Annex IX of REACH and cohorts 2A and 2B under column 2 of Section 8.7.3 of Annex IX of REACH.; and

order the defendant to pay the costs of these proceedings.

Pleas in law and main arguments

In support of the action, the applicants rely on five pleas in law.

1.First plea in law, alleging an error of law by misinterpreting Column 1 of Section 8.7.3 of Annex IX of REACH, and a manifest error of assessment by misapplying Column 1 of Section 8.7.3 of Annex IX of REACH, to require the Applicants to submit information on an extended one generation reproductive toxicity study (‘EOGRTS’) with a basic study design.

2.Second plea in law, alleging that the Agency breached the principle of proportionality and Article 25 of REACH by requiring the applicants to submit information on an EOGRTS with a basic study design.

3.Third plea in law, alleging that the Agency committed manifest errors of assessment, failed to take all available and relevant information into account, and breached the principles of legal certainty and of the protection of legitimate expectations, by requiring the applicants to submit information on an EOGRTS with a basic study design.

4.Fourth plea in law, alleging that the Agency breached the second paragraph of Column 2 of Section 8.7.3 of Annex IX of REACH and the principle of proportionality by failing to assess in the Contested Decision whether requiring Cohorts 2A and 2B as part of the EOGRTS is proportionate.

5.Fifth plea in law, alleging that the Agency committed manifest errors of assessment and breached the principles of legal certainty and of the protection of legitimate expectations by requiring Cohorts 2A and 2B as part of the EOGRTS.

ELI: http://data.europa.eu/eli/C/2024/770/oj

ISSN 1977-091X (electronic edition)

* * *

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia